Aetna Inc. (AET) Price Target Raised to $197.00

Aetna Inc. (NYSE:AET) had its price target upped by Citigroup Inc. from $183.00 to $197.00 in a research note issued to investors on Thursday. Citigroup Inc. currently has a buy rating on the stock.

AET has been the subject of a number of other reports. Deutsche Bank AG lifted their price objective on shares of Aetna from $144.00 to $157.00 and gave the stock a hold rating in a research note on Thursday, July 13th. Credit Suisse Group reissued an outperform rating and issued a $165.00 price objective (up from $160.00) on shares of Aetna in a research note on Thursday, July 13th. Jefferies Group LLC reaffirmed a hold rating and set a $163.00 price target (up from $157.00) on shares of Aetna in a research note on Friday, August 4th. Zacks Investment Research cut shares of Aetna from a buy rating to a hold rating in a research note on Monday, October 16th. Finally, Cantor Fitzgerald reaffirmed an overweight rating and set a $175.00 price target (up from $150.00) on shares of Aetna in a research note on Wednesday, August 9th. Eleven analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. Aetna currently has an average rating of Buy and a consensus target price of $170.34.

Aetna (NYSE:AET) traded up $4.67 on Thursday, reaching $176.99. 5,642,487 shares of the company traded hands, compared to its average volume of 2,701,255. The stock has a market capitalization of $57,716.44, a PE ratio of 17.33, a price-to-earnings-growth ratio of 1.61 and a beta of 0.61. Aetna has a 52 week low of $105.39 and a 52 week high of $184.98. The company has a quick ratio of 0.48, a current ratio of 0.53 and a debt-to-equity ratio of 0.52.

Aetna (NYSE:AET) last posted its earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.06 by $0.39. The company had revenue of $14.99 billion during the quarter, compared to analysts’ expectations of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. Aetna’s quarterly revenue was down 5.0% on a year-over-year basis. During the same period last year, the company posted $2.07 earnings per share. analysts anticipate that Aetna will post 9.79 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Aetna Inc. (AET) Price Target Raised to $197.00” was published by Community Financial News and is the sole property of of Community Financial News. If you are viewing this article on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this article can be viewed at https://www.com-unik.info/2017/11/05/aetna-inc-aet-price-target-raised-to-197-00.html.

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Thursday, October 12th were paid a dividend of $0.50 per share. The ex-dividend date was Wednesday, October 11th. This represents a $2.00 annualized dividend and a dividend yield of 1.13%. Aetna’s dividend payout ratio (DPR) is presently 37.04%.

In related news, President Karen S. Lynch sold 15,271 shares of the business’s stock in a transaction that occurred on Monday, September 18th. The shares were sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the transaction, the president now owns 64,261 shares in the company, valued at approximately $10,404,498.51. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Margaret M. Mccarthy sold 10,288 shares of the business’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the transaction, the executive vice president now owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of AET. Guardian Life Insurance Co. of America raised its stake in shares of Aetna by 0.7% during the 1st quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after acquiring an additional 9 shares in the last quarter. Marshall Wace North America L.P. bought a new position in shares of Aetna during the 1st quarter worth approximately $16,237,000. Menta Capital LLC bought a new position in shares of Aetna during the 1st quarter worth approximately $579,000. Aviance Capital Partners LLC grew its position in Aetna by 34.9% during the 1st quarter. Aviance Capital Partners LLC now owns 9,212 shares of the company’s stock worth $1,175,000 after purchasing an additional 2,382 shares during the last quarter. Finally, Meiji Yasuda Asset Management Co Ltd. grew its position in Aetna by 8.4% during the 1st quarter. Meiji Yasuda Asset Management Co Ltd. now owns 22,107 shares of the company’s stock worth $2,820,000 after purchasing an additional 1,710 shares during the last quarter. Hedge funds and other institutional investors own 89.45% of the company’s stock.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

What are top analysts saying about Aetna Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Aetna Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit